Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Cardiovascular Systems Inc | ex322-63020.htm |
| EX-32.1 - EX-32.1 - Cardiovascular Systems Inc | ex321-63020.htm |
| EX-31.2 - EX-31.2 - Cardiovascular Systems Inc | ex312-63020.htm |
| EX-31.1 - EX-31.1 - Cardiovascular Systems Inc | ex311-63020.htm |
| EX-10.47 - EX-10.47 - Cardiovascular Systems Inc | ex1047ati-csisupplyagr.htm |
| EX-10.3 - EX-10.3 - Cardiovascular Systems Inc | ex103-fy21directorcomp.htm |
| EX-10.2 - EX-10.2 - Cardiovascular Systems Inc | ex102-fy21execincentiv.htm |
| 10-K - 10-K - Cardiovascular Systems Inc | csii-20200630.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-228686) and Form S-8 (No. 333-158755, 333-160609, 333-168682, 333-175703, 333-182668, 333-189856, 333-197348, 333-200214, 333-208137, and 333-221651) of Cardiovascular Systems, Inc. of our report dated August 20, 2020 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Minneapolis, Minnesota
August 20, 2020